Skip to content
drillr.ai
Sign up

ALLR

Allarity Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$1.42
−0.70%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue345.0K320.0K———
Cost of Revenue(26.0K)———120.0K
Gross Profit371.0K320.0K——(120.0K)
Operating Expenses
R&D Expense5.5M6.6M6.1M7.1M6.9M
SG&A Expense5.6M6.3M11.4M10.0M10.0M
General & Admin Expense5.6M6.3M11.4M10.0M10.0M
Selling & Marketing Expense—————
Other Expenses26.0K—9.7M—17.6M
Total Operating Expenses11.2M12.9M27.2M17.1M34.5M
Cost and Expenses11.1M12.9M27.2M17.1M34.5M
Operating Income (EBIT)(10.8M)(12.6M)(27.2M)(17.1M)(34.5M)
Non-Operating
Interest Income722.0K801.0K533.0K22.0K30.0K
Interest Expense1.1M185.0K653.0K498.0K223.0K
Net Interest Income(342.0K)616.0K(120.0K)(476.0K)(193.0K)
Other Non-Op Income/Expense(1.5M)1.4M2.3M5.3M16.9M
Non-Operating Income (excl Interest)228.0K(1.6M)(3.0M)(5.8M)(17.1M)
EBT (Pre-Tax Income)(12.3M)(11.2M)(24.9M)(11.8M)(17.6M)
Income Tax Expense——(381.0K)83.0K(1.5M)
Bottom Line
Net Income(12.3M)(11.2M)(24.5M)(11.9M)(16.1M)
Earnings from Cont. Ops(12.3M)(11.2M)(24.5M)(11.9M)(16.1M)
Earnings from Discont. Ops—————
Bottom Line Net Income(12.3M)(11.2M)(25.2M)(20.4M)(21.1M)
Per Share
Basic EPS($0.78)($0.78)($15.79)($6,031.31)($31,799.09)
Diluted EPS($0.78)($0.78)($15.79)($6,031.31)($31,799.09)
Revenue Per Share$0.02$0.02$0.00$0.00$0.00
Shares
Basic Shares Outstanding15.9M14.4M1.6M3.3M11341
Diluted Shares Outstanding15.9M14.4M1.6M3.3M11341
Profitability Metrics
EBITDA(11.1M)(11.0M)(24.2M)(11.3M)(17.3M)
D&A(62.0K)(13.0K)9.0K37.0K60.0K
EBIT(11.0M)(11.0M)(24.2M)(11.3M)(17.4M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026